Skip to content
Aperlena

Poland - Pharmaceutical products - Supply of pharmaceutical products used under drug programmes and chemotherapy - 146 packages

Original Polska - Produkty farmaceutyczne - DOSTAWA PRODUKTÓW FARMACEUTYCZNYCH STOSOWANYCH W RAMACH PROGRAMÓW LEKOWYCH I CHEMIOTERAPII - 146 PAKIETÓW

Open Contract notice

Key facts

Closes in
19 days
Where
Poland Mazowiecki regionalny
Procedure
Open procedure Anyone may submit a bid, in one step, with no pre-selection. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33600000 Pharmaceutical products
Original language
Polish
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 5 days ago
Notice number
643734-2026
Watch this tender

If the deadline moves or the notice is corrected, we email you. Log in

  1. Published
  2. Today
  3. Deadline open for 31 days
  4. Awarded pending

Summary

Machine-generated summary

This tender concerns the supply of pharmaceutical products used in drug programmes and chemotherapy, divided into 146 packages. The products listed include oral anticancer medicines such as abemaciclib, alpelisib, brigatinib, capivasertib, crizotinib, nintedanib, niraparib, olaparib, osimertinib, palbociclib, ribociclib, sotorasib, tucatinib and abiraterone acetate, as well as concentrates and solutions for injection or infusion including atezolizumab, cemiplimab, durvalumab, ipilimumab, nivolumab, pembrolizumab, pertuzumab, trastuzumab in various forms, bevacizumab, cetuximab, aflibercept, chemotherapy agents such as carboplatin, cisplatin, docetaxel, doxorubicin, gemcitabine, capecitabine, cyclophosphamide, etoposide, fluorouracil and supportive medicines.

Description

DOSTAWA PRODUKTÓW FARMACEUTYCZNYCH STOSOWANYCH W RAMACH PROGRAMÓW LEKOWYCH I CHEMIOTERAPII - 146 PAKIETÓW Abemacyclib tabl.; Alpelisibum tabl.; Atezolizumabum 1200 mg koncentrat; Atezolizumabum 1875 mg, roztwór do wstrzykiwań; Brigatinibum tabl.; Capivasertibum tabl.; Cemiplimabum 350mg, koncentrat; Crizotinibum tabl.; Durwalumab koncentrat; Fruquintinibum kaps.; Ipilimumabum koncentrat; Mirvetuximabum soravtansinum koncentrat; Nintedanibum kaps.; Niraparibum kaps.; Nivolumabum koncentrat; Olaparibum tabl.; Osimertinibum tabl.; Palbociclibum tabl.; Pembrolizumabum 100 mg, koncentrat; Pertuzumabum 420 mg, koncentrat; Ribociclibum tabl.; Ripretinibum tabl.; Rucaparibum tabl.; Sacituzumabum govitecanum 200 mg, proszek; Serplulimabum; Sotorasibum tabl.; Talazoparibum kaps.; Tislelizumabum 100 mg, koncentrat; Trastuzumabum 600 mg, roztwór; Trastuzumab deruxtecan 100 mg, proszek; Trastuzumabum emtansinum proszek; Trastuzumabum + Pertuzumabum roztwór; Trifluridinum+ Tipiracilum; Tucatinibum tabl.; Abirateroni acetas tabl.; Acidum levofolinicum roztwór; Acidum zoledronicum; Aflibercept koncentrat; Anagrelidum; Bendamustinum hydrochloridum 100 mg; Bevacizumabum koncentrat; Bleomycini sulphas; Bortezomibum 3,5 mg; Cabazitaxelum koncentrat, 60mg; Cabazitaxelum koncentrat, 45 mg, 50 mg; Capecitabinum tabl.; Carboplatinum koncentrat; Cetuximabum roztwór; Chlorambucilum tabl.; Cisplatinum koncentrat; Cladribinum roztwór; Cyclophosphamidum koncentrat lub proszek; Cyclophosphamidum tabl. 50 mg; Dacarbazinum proszek; Darbepoetinum alfa roztwór; Denosumabum 120 mg, roztwór; Dexamethasoni phosphas 4 mg/ml roztwór; Dexamethasoni phosphas 8mg/ml, roztwór; Docetaxelum koncentrat; Doxorubicinum koncentrat lub roztwór; DOXORUBICINUM LIPOSOMANUM PEGYLATUM koncentrat; Doxorubicinum 50 mg; proszek, dyspersja i rozpuszczalnik; Epirubicini hydrochloridum koncentrat lub roztwór; Etoposidum, koncentrat; Fluorouracilum roztwór; Fulvestrantum roztwór; Gefitynibum tabl.; Gemcitabinum koncentrat; Ifosfamidum proszek; Imatynibum; Irinotecanum koncentrat; Lapatynibum tabl.; Lenalidomidum tabl.; Methotrexatum 50 mg/5 ml roztwór; Methotrexatum 5 g, koncentrat; Mitomycin 20 mg/ proszek; Netupitantum + Palonosetroni hydrochloridum kaps.; Oxaliplatinum koncentrat; Paclitaxelum koncentrat; Paclitaxelum albuminatum proszek; Panitumumab koncentrat; Pegfilgrastimum roztwór; Pemetreksedum koncentrat; Regorafenib tabl.; Ropeginterferonum alfa-2b roztwór; Rituximabum koncentrat; Sorafenibum; Sunitinibum kaps.; Temozolomidum kaps.; Thalidomide tabl.; Topotecanum koncentrat; Topotecanum kaps.; Trabectedinum proszek; Trastuzumabum proszek; Vinblastinum inj.; Vincristini sulfas roztwór; Vinorelbinum koncentrat; Vinorelbinum kaps.; Adagrasibum tabl.; Binimetinib tabl.; Encorafenibum kaps.; Tremelimumabum koncentrat; Entecavirum tabl.; Tenofovirum disoproxilum tabl.; Lamivudinum tabl.; Glecaprevirum + Pibrentasvirum tabl.; Sofosbuvir + Velpatasvir tabl.; Sofosbuvir + Velpatasvir + Voxilaprevir tabl.; Ofatumumabum; Ozanimodum kaps.; Ponesimodum tabl.; Cladribinum tabl.; Natalizumabum koncentrat; Ocrelizumabum 30mg/ml koncentrat, 40 mg/ml roztwór; Interferonum beta-1a 44 μg/0,5 ml roztwór; Interferonum beta-1a 30 μg/0,5 ml roztwór; Interferonum beta-1b 300 μg, proszek i rozpuszczalnik; Teriflunomidum 14 mg, tabl.; Dimethylis fumaras kaps.; Glatiramer acetate roztwór; Ublituximabum koncentrat; Upadacitinibum tabl.; Satralizumabum roztwór; Dupilumabum roztwór; Adalimumabum 40 mg; Bimekizumabum roztwór; Filgotinibum tabl.; Tocilizumabum 162 mg, roztwór; Tocilizumabum koncentrat; Golimumabum roztwór; Ixekizumabum roztwór; Sekukinumabum roztwór; Immunoglobulina ludzka 5g, roztwór; Cinacalcet tabl.; Afliberceptum 40 mg/ml roztwór; Aflibercept 114,3 mg/ml roztwór; Farycymab 120 mg/ml roztwór; Bevacizumabum 25 mg/ml, koncentrat; Epoetinum Alfa a 1000j; Nintedanibum; Roxadustatum tabl.; Darbepoetyna α; Methoxy Polyethylene glycol-epoetin-bet 1μg; Immunoglobulina ludzka 1g, roztwór; Metalyse proszek

Can I bid?

  • Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
  • The notice is written in Polish.
  • Certificates from another EU country? Check the equivalents on eCertis

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 5 days ago

More from this buyer

Full buyer profile

6 open tenders right now

This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Poland

Company Wins Total awarded Last win
URTICA Sp. z o.o. 228 €170.9M Sep 2026
Bialmed Sp. z o.o. 192 €19.5M Sep 2026
AESCULAP CHIFA SP. Z O.O. 146 €26.9M Sep 2026
Medtronic Poland Sp. z o.o. 139 €126.5M Sep 2026
Salus International Sp. z o.o. 133 €20.9M Sep 2026

Based on 15948 awards with a linked company profile over the last 2 years.

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€11,085,809
9,975 open across Europe right now
Buyer track record on Aperlena
134 notices tracked · 71 awarded
€168,600,129 in awarded contracts

Never miss a tender like this

896 new notices in Medical equipment & pharmaceuticals in Poland in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

19 days left

Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language